Telik (TELK) Move "Very Silly" - Feuerstein
Get Alerts TELK Hot Sheet
Join SI Premium – FREE
Biotech watcher Adam Feuerstein said "very silly" for Telik Inc. (NASDAQ: TELK) to be up 60% on orphan drug designation.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic hires Google chip veteran as it pushed into hardware - Bloomberg
- New York Fed raises Q3 2026 GDP forecast to 2.3%
- Holcim said to acquire part of James Hardie's EU business
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share